Search This Blog

Thursday, December 20, 2018

Celgene multiple myeloma treatment granted FDA orphan designation


Celgene’s multiple myeloma treatment was granted FDA orphan designation, according to a post to the agency’s website.
https://thefly.com/landingPageNews.php?id=2840181
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)